Influence of the time of the abolition of the dual desagregants therapy on frequency of resternotomy after CABG
Abstract
This paper is the analysis of the frequency of resternotomy after coronary artery bypass grafting (CABG) for the early postoperative bleeding depending of the time of the abolition of the
dual desagregants therapy in the preoperative period. This is the analysis of time when we can
cancel aspirine and clopidogrel or ticagrelor therapy before CABG. We analyses the necessity
of blood transfusions related to later cancellation of double desagregant therapy before CABG and possibility of preventing resternotomy for early postoperative bleeding associated with
late cancellation of antiplatelet agents. We concluded the importance of early cancellation of
double desagregants therapy as predictor of early postoperative bleeding and as well as a factor
contributing to an additional transfusion of donor blood.
Keywords:CABG, bleeding, double desagregants therapy, resternotomy, blood loss
Clin. Experiment. Surg. Petrovsky J. 2018; 1 (19): 34–8.
DOI: 10.24411/2308-1198-2018-00005
Received: 01.06.2017. Accepted: 25.01.2018.
References
1. Jessen C., Sharma R. Use fibrin glue in thoracic surgery. Ann Thorac Surg. 1985; 3: 9–21.
2. Myles P.S. Stopping aspirin before coronary artery surgery: between the devil and the deep blue sea. Circulation. 2011; 123 (6): 571–3.
3. Deja M.A., Kargul T., Domaradzki W., Stacel T., et al. Effects of preoperative aspirin in coronary artery bypass grafting: a double-blind, placebo-controlled, randomized trial. J Thorac Cardiovasc Surg. 2012; 144 (1): 204–9. doi: 10.1016/j.jtcvs.2012.04.004. Epub 2012 May 1.
4. Coronary bypass. The recommendations of the American College of Cardiology and the American Heart Association, an updated practical guide 2007 and the replacement of a special update.2011. 2012: 23–4. (in Russian)
5. Fox K.A., Mehta S.R., Peters R., Zhao F., et al. Benefits and Risks of the Combination of Clopidogrel and Aspirin in Patients Undergoing Surgical Revascularization for Non-ST-Elevation Acute Coronary Syndrome. The Clopidogrel in Unstable Angina to Prevent Recurrent ischemic Events (CURE) Trial. URL: http://circ.ahajournals.org.
6. American College of Chest Physicians. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2008; 133: 299S–339S.
7. Aspirin and coronary artery: a systematic review and meta-analysis. Br J Anesth. 2015; 115 (3): 376–85.
8. Kim J.H.-J., Newby L.K., Clare R.M., Shaw L.K., et al. Clopidogrel use and bleeding after coronary artery bypass graft surgery. Am Heart J. 2008; 156: 886–92.
9. Jacob M., Smedira N., Blackstone E., et al. Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in coronary artery bypass surgery. Circulation. 2011; 123 (6): 577–83. doi: 10.1161/CIRCULATIONAHA.110.957373.
10. Myles P.S., Smith J.A., Forbes A., Silbert B., et al.; for the ATACAS Investigators of the ANZCA Clinical Trials Network. Stopping vs continuing aspirin before coronary artery surgery. N Engl J Med. 2016; 374: 728–37. doi: 10.1056/NEJMoa1507688.